Ventas, Inc. (VTR) is scheduled to report third-quarter 2024 results on Oct. 30, after market close. The quarterly results are likely to display year-over-year growth in revenues and normalized funds from operations (FFO) per share.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.In the last reported quarter, this Chicago-based healthcare real estate investment trust (REIT) delivered a normalized FFO per share of 80 cents, beating the Zacks Consensus Estimate by 1.3%. The quarterly r ...

Shares of Ventas (VTR) have gained 48.9% in the past six months compared with the industry's growth of 15.8%. This healthcare real estate investment trust (REIT) is well-positioned to gain from its diverse portfolio of healthcare real estate assets in the key markets of the United States and the U.K. An aging population and the rise in healthcare expenditure by senior citizens are likely to benefit the senior housing operating portfolio (SHOP). The outpatient medical portfolio is expected to gain from favor ...

Ventas (VTR) secured an agreement ("2024 Kindred Agreements") with Kindred Healthcare, LLC and its parent company, ScionHealth. This agreement is regarding 23 long-term acute care hospitals ("LTACs") whose lease term is scheduled to mature on April 30, 2025, under the existing master lease between Ventas and Kindred. This move enhances patient care facilities, strengthens the existing master lease and provide upside for Ventas. The company also obtains rights to additional revenue-sharing rent and warrants. ...

Ventas' (VTR) senior housing operating portfolio (SHOP) is likely to benefit from the aging population and the rising healthcare expenditures by senior citizens. Its outpatient medical and research portfolio is expected to gain from the favorable outpatient visit trends and the rising need for research related to life-saving vaccines and therapeutics. A healthy balance sheet position is likely to support its growth endeavors. However, dependence on few tenants and high interest rates add to its concern. Las ...

Core Viewpoint - Ventas has significantly outperformed the Vanguard Real Estate ETF in 2024, achieving a total return of approximately 22% compared to the ETF's 10% gain, but its elevated valuation suggests a Hold rating is appropriate [2][14] Company Overview - Ventas is a healthcare REIT with 41% of its net operating income (NOI) derived from the Senior Housing Operating Portfolio (SHOP), 31% from the Outpatient Medical & Research Portfolio (OM&R), and 28% from Triple-Net Properties [3] - The company operates a total of 1,345 properties with a gross book value of $32.067 billion and an annual NOI of $2.083 billion [3] Operational Overview - In Q2 2024, Ventas reported a normalized FFO of $0.80 per share, reflecting a 7% year-over-year increase, driven by a 15.2% increase in same-store cash NOI in the SHOP portfolio [4] - The overall same-store cash NOI growth for the company was 7.8%, with modest increases in OM&R and Triple-Net portfolios at 3.3% and 2.6% respectively [4] Increased 2024 Guidance - Following strong Q2 performance, Ventas raised its full-year normalized FFO guidance to approximately $3.15 per share, representing a 5% year-over-year increase [5][6] Capital Structure - As of Q2 2024, Ventas had a net debt of $12.9 billion, with a market capitalization of $24.7 billion, resulting in net debt accounting for 34% of the enterprise value [7] - The weighted average interest rate on the company's debt is 4.3%, with only 9% of the debt at floating rates, limiting benefits from potential monetary policy easing [8] Market-Implied Cap Rate - The market-implied cap rate is approximately 5%, indicating that the strong NOI growth is already reflected in the company's valuation [9] General and Administrative Expenses - The company anticipates general and administrative expenses of about $158 million in 2024, which is relatively low compared to peers, suggesting efficient management [10] Prospects and Valuation - While robust NOI growth is expected to continue, it is anticipated to moderate to low-to-mid single digits due to occupancy limits in the SHOP portfolio [11] - The elevated normalized FFO multiple and limited near-term benefits from Fed rate cuts lead to a Hold rating for Ventas shares [11][14] Covered Call Strategy - To enhance returns, the company suggests a covered call strategy for investors holding Ventas shares, which could provide additional income and mitigate risks during market downturns [12][14]

Shares of Ventas (VTR) have gained 34.1% in the past six months compared with the industry's growth of 7.9%. This Chicago-based healthcare real estate investment trust (REIT) is well-positioned to gain from its diverse portfolio of healthcare real estate assets in the key markets of the United States and the U.K. An aging population and the rise in healthcare expenditure by senior citizens are likely to benefit the senior housing operating portfolio (SHOP). The outpatient medical portfolio is expected to ga ...

Ventas, Inc. (VTR) reported second-quarter 2024 normalized funds from operations (FFO) per share of 80 cents, which surpassed the Zacks Consensus Estimate of 79 cents. The reported figure increased 6.7% from the prior-year quarter's tally. Results reflect growth in occupancy in the SHOP same-store portfolio contributing to higher revenue generation. The company has improved its 2024 outlook. VTR clocked in revenues of $1.20 billion in the second quarter, which beat the Zacks Consensus Estimate of $1.19 bill ...

For the quarter ended June 2024, Ventas (VTR) reported revenue of $1.2 billion, up 8.6% over the same period last year. EPS came in at $0.80, compared to $0.26 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $1.19 billion, representing a surprise of +0.78%. The company delivered an EPS surprise of +1.27%, with the consensus EPS estimate being $0.79. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectati ...

Ventas (VTR) came out with quarterly funds from operations (FFO) of $0.80 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to FFO of $0.75 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an FFO surprise of 1.27%. A quarter ago, it was expected that this seniors housing real estate investment trust would post FFO of $0.74 per share when it actually produced FFO of $0.78, delivering a surprise of 5.41%. Over the last f ...

Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock. The consensus estimate for 'Revenues- Rental income- Triple-net leased' stands at $153.42 million. The estimate indicates a year-over-year chan ...